nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—Urticaria—Chlorambucil—ovarian cancer	0.00235	0.00235	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Vinorelbine—ovarian cancer	0.00235	0.00235	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Topotecan—ovarian cancer	0.00234	0.00234	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00234	0.00234	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Chlorambucil—ovarian cancer	0.00233	0.00233	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Chlorambucil—ovarian cancer	0.00233	0.00233	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Paclitaxel—ovarian cancer	0.00233	0.00233	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Paclitaxel—ovarian cancer	0.00232	0.00232	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Melphalan—ovarian cancer	0.00231	0.00231	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Epirubicin—ovarian cancer	0.0023	0.0023	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Melphalan—ovarian cancer	0.00229	0.00229	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Epirubicin—ovarian cancer	0.00229	0.00229	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Topotecan—ovarian cancer	0.00228	0.00228	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Topotecan—ovarian cancer	0.00227	0.00227	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Docetaxel—ovarian cancer	0.00225	0.00225	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00225	0.00225	CcSEcCtD
Sodium lauryl sulfate—Constipation—Topotecan—ovarian cancer	0.00225	0.00225	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Melphalan—ovarian cancer	0.00224	0.00224	CcSEcCtD
Sodium lauryl sulfate—Infection—Vinorelbine—ovarian cancer	0.00223	0.00223	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Melphalan—ovarian cancer	0.00222	0.00222	CcSEcCtD
Sodium lauryl sulfate—Bronchospasm—Docetaxel—ovarian cancer	0.00222	0.00222	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Vinorelbine—ovarian cancer	0.00219	0.00219	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Chlorambucil—ovarian cancer	0.00218	0.00218	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Topotecan—ovarian cancer	0.00215	0.00215	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Vinorelbine—ovarian cancer	0.00214	0.00214	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Doxorubicin—ovarian cancer	0.00213	0.00213	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Chlorambucil—ovarian cancer	0.00212	0.00212	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00212	0.00212	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Doxorubicin—ovarian cancer	0.00212	0.00212	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Epirubicin—ovarian cancer	0.0021	0.0021	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Vinorelbine—ovarian cancer	0.0021	0.0021	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Chlorambucil—ovarian cancer	0.00209	0.00209	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Topotecan—ovarian cancer	0.00209	0.00209	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Topotecan—ovarian cancer	0.00208	0.00208	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Topotecan—ovarian cancer	0.00208	0.00208	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Melphalan—ovarian cancer	0.00204	0.00204	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Epirubicin—ovarian cancer	0.00204	0.00204	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Chlorambucil—ovarian cancer	0.00202	0.00202	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Vinorelbine—ovarian cancer	0.00202	0.00202	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Vinorelbine—ovarian cancer	0.002	0.002	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00198	0.00198	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Docetaxel—ovarian cancer	0.00198	0.00198	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Docetaxel—ovarian cancer	0.00197	0.00197	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Vinorelbine—ovarian cancer	0.00195	0.00195	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Doxorubicin—ovarian cancer	0.00195	0.00195	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Epirubicin—ovarian cancer	0.00194	0.00194	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Vinorelbine—ovarian cancer	0.00194	0.00194	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Topotecan—ovarian cancer	0.00194	0.00194	CcSEcCtD
Sodium lauryl sulfate—Constipation—Vinorelbine—ovarian cancer	0.00192	0.00192	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Epirubicin—ovarian cancer	0.00191	0.00191	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Paclitaxel—ovarian cancer	0.0019	0.0019	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Melphalan—ovarian cancer	0.0019	0.0019	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Doxorubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Topotecan—ovarian cancer	0.00189	0.00189	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Chlorambucil—ovarian cancer	0.00188	0.00188	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Topotecan—ovarian cancer	0.00186	0.00186	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Epirubicin—ovarian cancer	0.00185	0.00185	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Melphalan—ovarian cancer	0.00185	0.00185	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00184	0.00184	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Paclitaxel—ovarian cancer	0.00183	0.00183	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Melphalan—ovarian cancer	0.00182	0.00182	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Paclitaxel—ovarian cancer	0.00181	0.00181	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Topotecan—ovarian cancer	0.0018	0.0018	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Docetaxel—ovarian cancer	0.0018	0.0018	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Epirubicin—ovarian cancer	0.0018	0.0018	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00179	0.00179	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Vinorelbine—ovarian cancer	0.00179	0.00179	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Vinorelbine—ovarian cancer	0.00178	0.00178	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Vinorelbine—ovarian cancer	0.00178	0.00178	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Doxorubicin—ovarian cancer	0.00176	0.00176	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Melphalan—ovarian cancer	0.00176	0.00176	CcSEcCtD
Sodium lauryl sulfate—Nausea—Chlorambucil—ovarian cancer	0.00175	0.00175	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Paclitaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Topotecan—ovarian cancer	0.00174	0.00174	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Doxorubicin—ovarian cancer	0.00171	0.00171	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Topotecan—ovarian cancer	0.00167	0.00167	CcSEcCtD
Sodium lauryl sulfate—Syncope—Paclitaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Sodium lauryl sulfate—Rash—Topotecan—ovarian cancer	0.00166	0.00166	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Vinorelbine—ovarian cancer	0.00166	0.00166	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Topotecan—ovarian cancer	0.00166	0.00166	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Epirubicin—ovarian cancer	0.00165	0.00165	CcSEcCtD
Sodium lauryl sulfate—Headache—Topotecan—ovarian cancer	0.00165	0.00165	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Paclitaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Melphalan—ovarian cancer	0.00164	0.00164	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Epirubicin—ovarian cancer	0.00164	0.00164	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Paclitaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Sodium lauryl sulfate—Rash—Melphalan—ovarian cancer	0.00162	0.00162	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Melphalan—ovarian cancer	0.00162	0.00162	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Vinorelbine—ovarian cancer	0.00161	0.00161	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Docetaxel—ovarian cancer	0.00161	0.00161	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Paclitaxel—ovarian cancer	0.00161	0.00161	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Epirubicin—ovarian cancer	0.0016	0.0016	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Vinorelbine—ovarian cancer	0.00159	0.00159	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Paclitaxel—ovarian cancer	0.00158	0.00158	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Paclitaxel—ovarian cancer	0.00157	0.00157	CcSEcCtD
Sodium lauryl sulfate—Nausea—Topotecan—ovarian cancer	0.00156	0.00156	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Vinorelbine—ovarian cancer	0.00154	0.00154	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Docetaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Epirubicin—ovarian cancer	0.00153	0.00153	CcSEcCtD
Sodium lauryl sulfate—Nausea—Melphalan—ovarian cancer	0.00153	0.00153	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Epirubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Doxorubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00151	0.00151	CcSEcCtD
Sodium lauryl sulfate—Oedema—Paclitaxel—ovarian cancer	0.00151	0.00151	CcSEcCtD
Sodium lauryl sulfate—Infection—Paclitaxel—ovarian cancer	0.0015	0.0015	CcSEcCtD
Sodium lauryl sulfate—Shock—Paclitaxel—ovarian cancer	0.00149	0.00149	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Vinorelbine—ovarian cancer	0.00149	0.00149	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Doxorubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Paclitaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Epirubicin—ovarian cancer	0.00146	0.00146	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00146	0.00146	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Paclitaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vinorelbine—ovarian cancer	0.00143	0.00143	CcSEcCtD
Sodium lauryl sulfate—Rash—Vinorelbine—ovarian cancer	0.00142	0.00142	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Vinorelbine—ovarian cancer	0.00142	0.00142	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Doxorubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Paclitaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Sodium lauryl sulfate—Headache—Vinorelbine—ovarian cancer	0.00141	0.00141	CcSEcCtD
Sodium lauryl sulfate—Syncope—Docetaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Doxorubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Docetaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Docetaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Paclitaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Doxorubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Paclitaxel—ovarian cancer	0.00135	0.00135	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Docetaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vinorelbine—ovarian cancer	0.00134	0.00134	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Paclitaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Paclitaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Sodium lauryl sulfate—Constipation—Paclitaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Sodium lauryl sulfate—Oedema—Docetaxel—ovarian cancer	0.00128	0.00128	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Docetaxel—ovarian cancer	0.00128	0.00128	CcSEcCtD
Sodium lauryl sulfate—Infection—Docetaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Sodium lauryl sulfate—Shock—Docetaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Docetaxel—ovarian cancer	0.00125	0.00125	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Docetaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Epirubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Paclitaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Docetaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Paclitaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Paclitaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Docetaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Docetaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Docetaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Paclitaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Docetaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Constipation—Docetaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Epirubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Paclitaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Paclitaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Paclitaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Docetaxel—ovarian cancer	0.00101	0.00101	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Docetaxel—ovarian cancer	0.00101	0.00101	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Doxorubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Paclitaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Epirubicin—ovarian cancer	0.000998	0.000998	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Doxorubicin—ovarian cancer	0.000966	0.000966	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Paclitaxel—ovarian cancer	0.000962	0.000962	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Doxorubicin—ovarian cancer	0.00096	0.00096	CcSEcCtD
Sodium lauryl sulfate—Rash—Paclitaxel—ovarian cancer	0.000954	0.000954	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Paclitaxel—ovarian cancer	0.000953	0.000953	CcSEcCtD
Sodium lauryl sulfate—Syncope—Epirubicin—ovarian cancer	0.00095	0.00095	CcSEcCtD
Sodium lauryl sulfate—Headache—Paclitaxel—ovarian cancer	0.000947	0.000947	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Docetaxel—ovarian cancer	0.000944	0.000944	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Epirubicin—ovarian cancer	0.000936	0.000936	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Epirubicin—ovarian cancer	0.000931	0.000931	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Doxorubicin—ovarian cancer	0.000924	0.000924	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Docetaxel—ovarian cancer	0.00092	0.00092	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Epirubicin—ovarian cancer	0.000918	0.000918	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Docetaxel—ovarian cancer	0.000907	0.000907	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Epirubicin—ovarian cancer	0.000902	0.000902	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Epirubicin—ovarian cancer	0.000899	0.000899	CcSEcCtD
Sodium lauryl sulfate—Nausea—Paclitaxel—ovarian cancer	0.000898	0.000898	CcSEcCtD
Sodium lauryl sulfate—Syncope—Doxorubicin—ovarian cancer	0.000879	0.000879	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Docetaxel—ovarian cancer	0.000877	0.000877	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Doxorubicin—ovarian cancer	0.000866	0.000866	CcSEcCtD
Sodium lauryl sulfate—Oedema—Epirubicin—ovarian cancer	0.000865	0.000865	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000865	0.000865	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Doxorubicin—ovarian cancer	0.000862	0.000862	CcSEcCtD
Sodium lauryl sulfate—Infection—Epirubicin—ovarian cancer	0.000859	0.000859	CcSEcCtD
Sodium lauryl sulfate—Shock—Epirubicin—ovarian cancer	0.000851	0.000851	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Doxorubicin—ovarian cancer	0.000849	0.000849	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Docetaxel—ovarian cancer	0.000848	0.000848	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Epirubicin—ovarian cancer	0.000844	0.000844	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Epirubicin—ovarian cancer	0.000836	0.000836	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Doxorubicin—ovarian cancer	0.000835	0.000835	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Doxorubicin—ovarian cancer	0.000832	0.000832	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Epirubicin—ovarian cancer	0.000824	0.000824	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Docetaxel—ovarian cancer	0.000815	0.000815	CcSEcCtD
Sodium lauryl sulfate—Rash—Docetaxel—ovarian cancer	0.000808	0.000808	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Epirubicin—ovarian cancer	0.000808	0.000808	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Docetaxel—ovarian cancer	0.000808	0.000808	CcSEcCtD
Sodium lauryl sulfate—Headache—Docetaxel—ovarian cancer	0.000803	0.000803	CcSEcCtD
Sodium lauryl sulfate—Oedema—Doxorubicin—ovarian cancer	0.0008	0.0008	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.0008	0.0008	CcSEcCtD
Sodium lauryl sulfate—Infection—Doxorubicin—ovarian cancer	0.000795	0.000795	CcSEcCtD
Sodium lauryl sulfate—Shock—Doxorubicin—ovarian cancer	0.000787	0.000787	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Doxorubicin—ovarian cancer	0.000781	0.000781	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Epirubicin—ovarian cancer	0.000776	0.000776	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000773	0.000773	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Epirubicin—ovarian cancer	0.000771	0.000771	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Doxorubicin—ovarian cancer	0.000763	0.000763	CcSEcCtD
Sodium lauryl sulfate—Nausea—Docetaxel—ovarian cancer	0.000761	0.000761	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Epirubicin—ovarian cancer	0.000752	0.000752	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Doxorubicin—ovarian cancer	0.000748	0.000748	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Epirubicin—ovarian cancer	0.000745	0.000745	CcSEcCtD
Sodium lauryl sulfate—Constipation—Epirubicin—ovarian cancer	0.000739	0.000739	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Doxorubicin—ovarian cancer	0.000718	0.000718	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Doxorubicin—ovarian cancer	0.000713	0.000713	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000707	0.000707	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Doxorubicin—ovarian cancer	0.000695	0.000695	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Doxorubicin—ovarian cancer	0.00069	0.00069	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Epirubicin—ovarian cancer	0.000687	0.000687	CcSEcCtD
Sodium lauryl sulfate—Constipation—Doxorubicin—ovarian cancer	0.000684	0.000684	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Epirubicin—ovarian cancer	0.000684	0.000684	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Epirubicin—ovarian cancer	0.000684	0.000684	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000654	0.000654	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Epirubicin—ovarian cancer	0.000637	0.000637	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Doxorubicin—ovarian cancer	0.000636	0.000636	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Doxorubicin—ovarian cancer	0.000632	0.000632	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Doxorubicin—ovarian cancer	0.000632	0.000632	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Epirubicin—ovarian cancer	0.00062	0.00062	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Epirubicin—ovarian cancer	0.000612	0.000612	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Epirubicin—ovarian cancer	0.000592	0.000592	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000589	0.000589	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Doxorubicin—ovarian cancer	0.000574	0.000574	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Epirubicin—ovarian cancer	0.000572	0.000572	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Doxorubicin—ovarian cancer	0.000566	0.000566	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Epirubicin—ovarian cancer	0.00055	0.00055	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Doxorubicin—ovarian cancer	0.000547	0.000547	CcSEcCtD
Sodium lauryl sulfate—Rash—Epirubicin—ovarian cancer	0.000545	0.000545	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Epirubicin—ovarian cancer	0.000545	0.000545	CcSEcCtD
Sodium lauryl sulfate—Headache—Epirubicin—ovarian cancer	0.000542	0.000542	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Doxorubicin—ovarian cancer	0.000529	0.000529	CcSEcCtD
Sodium lauryl sulfate—Nausea—Epirubicin—ovarian cancer	0.000514	0.000514	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Doxorubicin—ovarian cancer	0.000509	0.000509	CcSEcCtD
Sodium lauryl sulfate—Rash—Doxorubicin—ovarian cancer	0.000504	0.000504	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Doxorubicin—ovarian cancer	0.000504	0.000504	CcSEcCtD
Sodium lauryl sulfate—Headache—Doxorubicin—ovarian cancer	0.000501	0.000501	CcSEcCtD
Sodium lauryl sulfate—Nausea—Doxorubicin—ovarian cancer	0.000475	0.000475	CcSEcCtD
